Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 253 | 3 | 253 | 3 | 3 |
| Gross Profit | 253 | 3 | 253 | 3 | 3 |
| Operating Expenses | 2,276 | 2,352 | 2,522 | 2,590 | 4,221 |
| Operating Income | -2,023 | -2,349 | -2,269 | -2,588 | -4,218 |
| Interest Expense | 1 | 2 | 3 | 1 | 16 |
| Other Income | 1,397 | 204 | -1,044 | 2,456 | -415 |
| Pre-tax Income | -627 | -2,147 | -3,316 | -134 | -4,649 |
| Net Income Continuous | -627 | -2,147 | -3,316 | -134 | -4,649 |
| Net Income | $-627 | $-2,147 | $-3,316 | $-134 | $-4,649 |
| EPS Basic Total Ops | -3,732.39 | -12,591.18 | -10,792.46 | -899.37 | -35,075.44 |
| EPS Basic Continuous Ops | -3,724.88 | -12,773.17 | -10,787.08 | -855.70 | -35,119.64 |
| EPS Diluted Total Ops | -3,732.39 | -12,591.18 | 4,496.84 | -16,188.67 | -35,075.44 |
| EPS Diluted Continuous Ops | -3,724.88 | -12,773.17 | -10,793.25 | -849.54 | -35,119.64 |
| EBITDA(a) | $-1,976 | $-2,282 | $-2,213 | $-2,535 | $-4,138 |